4.6 Review

Myeloid CD169/Siglec1: An immunoregulatory biomarker in viral disease

Journal

FRONTIERS IN MEDICINE
Volume 9, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fmed.2022.979373

Keywords

CD169; Siglec1; Sialoadhesin; infection; respiratory infection; immune response; respiratory virus; SARS-CoV-2

Funding

  1. Universities Giessen and Marburg Lung Center (UGMLC)
  2. German Center for Lung Research (DZL), University Hospital Giessen and Marburg (UKGM)
  3. Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [SFB 1021, 197785619, KFO 309, 284237345, SK 317/1-1, 428518790]
  4. Foundation for Pathobiochemistry and Molecular Diagnostics

Ask authors/readers for more resources

CD169, also known as Siglec1 or Sialoadhesin, is a surface adhesion molecule on human myeloid cells that acts as a receptor for sialylated molecular structures. Recent data suggest that CD169 may be a novel biomarker for viral infections, such as SARS-CoV-2, RSV, and HIV. CD169 not only functions in pathogen elimination, but also plays a role in connecting innate and adaptive immunity through antigen presentation and pathogen elimination. However, our knowledge about CD169's kinetics, induction mechanisms, signaling pathways, and its precise role in host-pathogen interaction remains limited.
CD169, also known as Siglec1 or Sialoadhesin (Sn), is a surface adhesion molecule on human myeloid cells. Being part of the Siglec family, it acts as a receptor for sialylated molecular structures, which are found among various pathogenic and non-pathogenic ligands. Recent data suggest that CD169 may represent a promising new biomarker in acute respiratory and non-respiratory viral infections, such as SARS-CoV-2, Respiratory syncytial virus (RSV) and Human immunodeficiency virus (HIV). Therein lies a great potential to sufficiently differentiate viral from bacterial infection, which has been an incessant challenge in the clinical management of infectious disease. CD169 equips myeloid cells with functions, reaching far beyond pathogen elimination. In fact, CD169 seems to crosslink innate and adaptive immunity by antigen presentation and consecutive pathogen elimination, embodying a substantial pillar of immunoregulation. Yet, our knowledge about the kinetics, mechanisms of induction, signaling pathways and its precise role in host-pathogen interaction remains largely obscure. In this review, we describe the role of CD169 as a potentially novel diagnostic biomarker for respiratory viral infection by evaluating its strengths and weaknesses and considering host factors that are involved in pathogenesis of virus infection. Finally, this brief review aims to point out shortcomings of available evidence, thus, guiding future work revolving the topic.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available